Clinical determinants of response to irinotecan-based therapy derived from cell line models.

MLA

Allen, Wendy L., et al. “Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 14, no. 20, Oct. 2008, pp. 6647–55. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-08-0452.

APA

Allen, W. L., Coyle, V. M., Jithesh, P. V., Proutski, I., Stevenson, L., Fenning, C., Longley, D. B., Wilson, R. H., Gordon, M., Lenz, H.-J., & Johnston, P. G. (2008). Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(20), 6647–6655. https://doi.org/10.1158/1078-0432.CCR-08-0452

Chicago

Allen, Wendy L, Vicky M Coyle, Puthen V Jithesh, Irina Proutski, Leanne Stevenson, Cathy Fenning, Daniel B Longley, et al. 2008. “Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 14 (20): 6647–55. doi:10.1158/1078-0432.CCR-08-0452.